4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-21-002160
CIK 0001583107other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:07 PM ET
Size
4.5 KB
Accession
0001179110-21-002160
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-02-20$18.79/sh−3,984$74,859→ 184,704 total
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:07 PM ET
- Size
- 4.5 KB